Provided herein are methods for treating or preventing ETS overexpressing castration-resistant prostate cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having ETS overexpressing castration-resistant prostate cancer.
申请公布号
WO2013138560(A1)
申请公布日期
2013.09.19
申请号
WO2013US31217
申请日期
2013.03.14
申请人
SIGNAL PHARMACEUTICALS, LLC
发明人
XU, SHUICHAN;HEGE, KRISTEN, MAE;RAYMON, HEATHER;TSUJI, TOSHIYA;SAPINOSO, LISA
